Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia
Completed · Phase 1
Conditions studied: Leukemia
In brief
RATIONALE: Drugs used in chemotherapy, such as temozolomide, work in different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: This phase I trial is studying the side effects and best dose of temozolomide in treating young patients with refractory or recurrent leukemia.
Key facts
- Study ID
- NCT00083070
- Run by
- Children's Oncology Group
- People needed
- 16
- Starts
- 2004-03-01
- Expected to finish
- 2008-06-01
- Last updated by the study team
- 2014-02-20
Who can join
Age: 1 and older, up to 21. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford Cancer Center at Stanford University Medical Center — Stanford, California, United States
- Indiana University Cancer Center — Indianapolis, Indiana, United States
- Fairview University Medical Center - University Campus — Minneapolis, Minnesota, United States
- Mayo Clinic Cancer Center — Rochester, Minnesota, United States
- University of Mississippi Medical Center — Jackson, Mississippi, United States
- Herbert Irving Comprehensive Cancer Center at Columbia University — New York, New York, United States
- SUNY Upstate Medical University Hospital — Syracuse, New York, United States
- Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States
- Children's Hospital of Pittsburgh — Pittsburgh, Pennsylvania, United States
- St. Jude Children's Research Hospital — Memphis, Tennessee, United States
- Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas — Dallas, Texas, United States
- Baylor University Medical Center - Houston — Houston, Texas, United States
- Children's Hospital and Regional Medical Center - Seattle — Seattle, Washington, United States
- Hospital for Sick Children — Toronto, Ontario, Canada
- Hopital Sainte Justine — Montreal, Quebec, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.